Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2322031001
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ljumanovic, R.
Right arrow Articles by Castelijns, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ljumanovic, R.
Right arrow Articles by Castelijns, J. A.
(Radiology 2004;232:440-448.)
© RSNA, 2004


Head and Neck Imaging

Supraglottic Carcinoma Treated with Curative Radiation Therapy: Identification of Prognostic Groups with MR Imaging1

Redina Ljumanovic, MD, Johannes A. Langendijk, MD, PhD, Barry Schenk, MD, Menno Van Wattingen, MD, Dirk L. Knol, PhD, C. René Leemans, MD, PhD and Jonas A. Castelijns, BSc, MD, PhD

1 From the Departments of Radiology (R.L., B.S., M.V.W., J.A.C.), Radiation Oncology (J.A.L.), Clinical Epidemiology and Biostatistics (D.L.K.), and Otolaryngology/Head-Neck Surgery (C.R.L.), VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. Received June 25, 2003; revision requested September 3; final revision received November 25; accepted January 5, 2004. Address correspondence to R.L. (e-mail: redina.ljumanovic@vumc.nl).

PURPOSE: To retrospectively assess the prognostic meaning of tumor characteristics depicted on pretreatment magnetic resonance (MR) images for local outcome in supraglottic squamous cell carcinoma treated with definitive radiation therapy.

MATERIALS AND METHODS: Pretreatment MR images acquired in 84 patients with supraglottic carcinoma treated with curative radiation therapy were reviewed for tumor involvement of laryngeal sites including glottis, subglottis, pre-epiglottic space, laryngeal cartilages, and hypopharynx, and for extralaryngeal extension. The volume of each tumor was estimated, and mean tumor volume was calculated for the group of tumors in each T staging category.

RESULTS: Results of univariate analysis showed MR imaging–determined primary tumor volume (P = .03), involvement of pre-epiglottic space (P = .008), abnormal signal intensity in thyroid cartilage (P = .04), and extralaryngeal extension beyond thyroid and/or cricoid cartilage (P = .02) to be significant predictors of local control rate. Results of multivariate analysis with the Cox regression model confirmed statistical significance for invasion of pre-epiglottic space (P = .004) and for abnormal signal intensities in thyroid cartilage adjacent to the anterior commissure (P = .04) and in cricoid cartilage (P = .01). Five-year local control rates were calculated from the regression coefficients of three independent MR imaging prognostic factors, and three prognostic groups were identified on the basis of these control rates. The 5-year local control rate in the high-risk group was 35%, significantly lower than the rates in the intermediate- and low-risk groups (60% and 89%, respectively; P = .002).

CONCLUSION: MR imaging–determined pre-epiglottic space involvement and abnormal signal intensities in the thyroid cartilage adjacent to the anterior commissure and/or the cricoid cartilage are strong predictors of local outcome in supraglottic carcinoma treated with definitive radiation therapy.

© RSNA, 2004

Index terms: Cartilage, MR, 27.12141 • Larynx, CT, 27.1211 • Larynx, MR, 27.12141 • Larynx, neoplasms, 27.373 • Larynx, therapeutic radiology




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
S. Bisdas, Z. Rumboldt, J. Wagenblast, M. Baghi, T.S. Koh, M. Hambek, T.J. Vogl, and M.G. Mack
Response and Progression-Free Survival in Oropharynx Squamous Cell Carcinoma Assessed by Pretreatment Perfusion CT: Comparison with Tumor Volume Measurements
AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 793 - 799.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Becker, P. Zbaren, J. W. Casselman, R. Kohler, P. Dulguerov, and C. D. Becker
Neoplastic Invasion of Laryngeal Cartilage: Reassessment of Criteria for Diagnosis at MR Imaging
Radiology, November 1, 2008; 249(2): 551 - 559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. Ljumanovic, P.J.W. Pouwels, J.A. Langendijk, D.L. Knol, P. van der Valk, C.R. Leemans, and J.A. Castelijns
Has the Degree of Contrast Enhancement with MR Imaging in Laryngeal Carcinoma Added Value to Anatomic Parameters Regarding Prediction of Response to Radiation Therapy?
AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1540 - 1546.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. G. Pfister, S. A. Laurie, G. S. Weinstein, W. M. Mendenhall, D. J. Adelstein, K. K. Ang, G. L. Clayman, S. G. Fisher, A. A. Forastiere, L. B. Harrison, et al.
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
J. Clin. Oncol., August 1, 2006; 24(22): 3693 - 3704.
[Abstract] [Full Text] [PDF]